PT  - JOURNAL ARTICLE
AU  - Julia Pastorello
AU  - Nicolas Almeida Leal da Silva
AU  - Natalia Bassani Schuch
AU  - Emanuela Lando
TI  - Gross hematuria secondary to use of carboplatin in neoadjuvant treatment of breast cancer with HER2 overexpression
AID  - 10.1136/bcr-2021-245407
DP  - 2022 Sep 01
TA  - BMJ Case Reports
PG  - e245407
VI  - 15
IP  - 9
4099  - http://casereports.bmj.com/content/15/9/e245407.short
4100  - http://casereports.bmj.com/content/15/9/e245407.full
SO  - BMJ Case Reports2022 Sep 01; 15
AB  - Breast cancer is a high prevalent neoplasia in women worldwide, and platinum compounds are widely used to treat it. On rare occasions, macroscopic hematuria associated with carboplatin has been identified. Thus, the present study aims to report a rare case of a female patient diagnosed with invasive ductal carcinoma, which presented hematuria secondary to carboplatin, showing improvement of the condition after 4 days of expectant treatment with clot lavage. Due to the scant description of hematuria secondary to carboplatin in the scientific literature, it is essential to report such case in order to assist and enrich the understanding of this event.